Mitochondria identified as key player in a rare disease causing microcephaly

by IRB Barcelona - Instituto de Investigación Biomédica

The study has identified the cellular mechanism explaining why certain errors in chromosome division can lead to microcephaly, a condition where the brain develops to a smaller than average size

Read more

Researchers at IRB Barcelona discover how mitochondria drive autophagy

by IRB Barcelona - Instituto de Investigación Biomédica

Using gene editing with CRISPR-Cas9, the team has been able to study these proteins without altering them or producing them in excess, thereby allowing observation of their true function.

Read more

The drug SAR405, the best inhibitor of autophagy

by IRB Lleida. Institut de Recerca Biomèdica

UdL research questions use of 3-methyladenine in studies because of its toxicity

Read more

New pathway to attack tumor cells identified

by CSIC - Centro Superior de Investigaciones Científicas

A study led by researchers from the Institut de Neurociències (INc-UAB), in collaboration with the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), describes a new mechanism by which the an...

Read more

AbilityPharma publishes full characterization of mechanism of action of ABTL0812, a Phase II clinical inducer of cytotoxic autophagy in cancer cells, in Autophagy journal

by AbilityPharma

The biopharmaceutical company Ability Pharmaceuticals SL announced today that the full description of the mechanism of action of ABTL0812 has been published in the prestigious Autophagy journal (impac...

Read more

COST Action BM1307 PROTEOSTASIS - 'European network to integrate research on intracellular proteolysis pathways in health and disease' – ends in April 2018

by CIC bioGUNE

The COST Action PROTEOSTASIS BM1307, coordinated by Dr. Rosa Barrio (group leader at CIC bioGUNE) ended on the 24th of April 2018. This European network gathered 274 group members from almost all coun...

Read more

IRBLleida researchers open a new door to improve cancer treatment

by IRB Lleida. Institut de Recerca Biomèdica

Researchers at the Pharmacology Unit IRBLleida have trials with several models of cell cultures, including some derived from tumors of patients, exposing them to media without nutrients and trophic fa...

Read more

New mechanism of antitumor action identified

by Vall d’Hebron

By activating the PPAR receptors, ABTL0812 induces over-expression of TRIB3 protein, which binds to the Akt oncogene and inhibits the Akt/mTOR axis.

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Rethinking Alzheimer’s clinical trials...

by Fundació Clínic per a la Recerca Biomèdica

A paper published in Alzheimer’s & Dementia: The Journal of the Alzh...

Photos Stream